Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
99,229,408
-
Share change
-
-6,561,662
-
Total reported value
-
$214,317,494
-
Put/Call ratio
-
84%
-
Price per share
-
$2.16
-
Number of holders
-
129
-
Value change
-
-$15,871,926
-
Number of buys
-
46
-
Number of sells
-
79
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q3 2019
As of 30 Sep 2019,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
99,229,408 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRANDES INVESTMENT PARTNERS, LP, NORTHERN TRUST CORP, Connor, Clark & Lunn Investment Management Ltd., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
129
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.